SOURCE: StockCall

StockCall

April 20, 2011 09:03 ET

Equity Research on Baxter International Inc. and Covidien plc -- Medical Instruments & Supplies Companies Look to Sealants to Boost Sales

JOHANNESBURG, SOUTH AFRICA--(Marketwire - Apr 20, 2011) - www.stockcall.com/ offers investors comprehensive research on the Medical Instruments & Supplies industry and has completed analytical research on Baxter International Inc. (NYSE: BAX) and Covidien plc (NYSE: COV). Register with us today at www.stockcall.com/ to have free access to these researches.

The Medical Instruments & Supplies Industry relies on research and development projects to bring new products to the market and improve their ability to care for patients while also bolstering sales figures. It is of utmost importance then that companies in this industry keep their product pipelines moving through clinical trials to FDA approval. Register now at https://stockcall.com/development/stockcall/page.php?name=register.html to have free access to our reports on the Medical Instruments & Supplies industry.

www.stockcall.com/ is an online platform where investors doing their due-diligence on the Medical Instruments & Supplies industry can have easy and free access to our analyst research and opinions on Baxter International Inc. and Covidien plc; investors and shareholders of these companies can simply register for a complimentary membership at https://stockcall.com/development/stockcall/page.php?name=register.html.

One area that has recently been explored by companies such as Baxter International Inc. and Covidien plc is that of sealants. Far beyond the days of bandages and band-aids, companies are developing advanced sealants that aid in reducing swelling as well as improving skin adherence. Baxter International recently announced the findings of its phase III study which, among other things, looked into using their ARTISS product to improve tissue adherence for facelift surgery patients. Baxter International Inc. research report is accessible for free by registering today at www.stockcall.com/BAX200411.pdf.

Covidien also made an announcement recently, stating that their DuraSeal Exact spine sealant had just been approved by the FDA. Covidien plc research report is available for free by signing up now at www.stockcall.com/COV200411.pdf.

While sealants are what some in the industry are focusing on now, new products with possible life-saving potential will keep many interested in the industry moving forward. Visit www.stockcall.com/ to see how companies in this industry have grown over the past years and how they are expected to perform in the future.

About StockCall.com
StockCall.com is a financial website where investors can have easy, precise and comprehensive research and opinions on stocks making the headlines.

Contact Information